These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12472800)

  • 1. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
    Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
    Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
    Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonyl stress reduction in peritoneal dialysis fluid: development of a novel high-affinity adsorption bead.
    Yamamoto M; Izuhara Y; Kakuta T; Takizawa S; Fujita A; Higaki T; van Ypersele de Strihou C; Miyata T
    Perit Dial Int; 2007; 27(3):300-8. PubMed ID: 17468479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
    Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
    Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?
    Wieslander AP; Andrén AH; Nilsson-Thorell C; Muscalu N; Kjellstrand PT; Rippe B
    Perit Dial Int; 1995; 15(8):348-52. PubMed ID: 8785233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis.
    Wieslander AP; Deppisch R; Svensson E; Forsbäck G; Speidel R; Rippe B
    Perit Dial Int; 1995; 15(2):158-64. PubMed ID: 7612737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
    Bazargani F
    Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
    Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
    Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells.
    Linden T; Musi B; Järkelid L; Forsbäck G; Kjellstrand P; Deppisch R; Wieslander A
    Perit Dial Int; 2001; 21(6):607-10. PubMed ID: 11783771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
    Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
    Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
    Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
    Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes.
    Nilsson-Thorell CB; Muscalu N; Andrén AH; Kjellstrand PT; Wieslander AP
    Perit Dial Int; 1993; 13(3):208-13. PubMed ID: 8369351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
    Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
    Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.
    Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J
    J Artif Organs; 2007; 10(1):47-51. PubMed ID: 17380297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.